Weatherstone Capital Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
$462K Buy
7,102
+78
+1% +$5.18K 0.49% 38
2018
Q4
$439K Buy
7,024
+204
+3% +$14.3K 0.11% 108
2018
Q3
$527K Buy
6,820
+685
+11% +$51.7K 0.4% 39
2018
Q2
$435K Sell
6,135
-172
-3% -$12.1K 0.35% 28
2018
Q1
$475K Buy
6,307
+74
+1% +$5.88K 0.36% 31
2017
Q4
$447K Buy
6,233
+722
+13% +$54.8K 0.3% 40
2017
Q3
$447K Buy
5,511
+37
+0.7% +$2.83K 0.31% 34
2017
Q2
$387K Buy
5,474
+989
+22% +$65.8K 0.26% 47
2017
Q1
$305K Sell
4,485
-2,442
-35% -$172K 0.34% 42
2016
Q4
$496K Buy
+6,927
New +$515K 0.32% 29
2016
Q1
Sell
-2,058
Closed -$208K 85
2015
Q4
$208K Buy
+2,058
New +$214K 0.24% 72

Other funds holding GILD

Weatherstone Capital Management's GILD Position: Q1 2019 in Review

Weatherstone Capital Management increased its Gilead Sciences (GILD) stake by 1.1% in Q1 2019, buying an estimated $5.18K and bringing the position to 7,102 shares worth $462K. The position accounts for 0.49% of the portfolio, ranked #38.

Weatherstone Capital Management first reported a position in GILD in Q4 2015 and has held it in 11 quarters since. The position peaked at $527K in Q3 2018. 1,491 funds tracked by Wall St. Rank hold GILD as of Q1 2019.

  • Weatherstone Capital Management held 7,102 shares of Gilead Sciences worth $462K as of Q1 2019.
  • Weatherstone Capital Management bought 78 Gilead Sciences shares in Q1 2019, an estimated $5.18K.
  • Gilead Sciences made up 0.49% of Weatherstone Capital Management's portfolio in Q1 2019, its #38 holding.
  • Weatherstone Capital Management first reported a position in Gilead Sciences in Q4 2015 and has held it in 11 quarters since.
  • Weatherstone Capital Management's Gilead Sciences position peaked at $527K in Q3 2018.
  • 1,491 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2019.

Based on Weatherstone Capital Management's 13F filing for Q1 2019, filed 16 Apr 2019.